Current concepts in antibiotic-resistant Gram-negative bacteria

Julian A. Torres Isasiga, Maria Virginia Villegas, John P. Quinn

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Gram-negative bacteria are the dominant killers among bacterial pathogens in the intensive care unit. Antibiotic resistance has become a threat in hospital settings and efforts are being made to understand the underlying mechanisms. This review describes current data on the most important mechanisms of resistance in prevalent Gram-negative pathogens as well as newer therapeutic options.

Original languageEnglish (US)
Pages (from-to)833-843
Number of pages11
JournalExpert Review of Anti-Infective Therapy
Volume5
Issue number5
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Microbial Drug Resistance
Gram-Negative Bacteria
Intensive Care Units
Anti-Bacterial Agents
Therapeutics

Keywords

  • Bacterial resistance
  • Carbapenems
  • Gram-negatives
  • Mechanisms of resistance
  • Tigecycline

ASJC Scopus subject areas

  • Infectious Diseases
  • Parasitology

Cite this

Current concepts in antibiotic-resistant Gram-negative bacteria. / Torres Isasiga, Julian A.; Villegas, Maria Virginia; Quinn, John P.

In: Expert Review of Anti-Infective Therapy, Vol. 5, No. 5, 01.10.2007, p. 833-843.

Research output: Contribution to journalReview article

Torres Isasiga, Julian A. ; Villegas, Maria Virginia ; Quinn, John P. / Current concepts in antibiotic-resistant Gram-negative bacteria. In: Expert Review of Anti-Infective Therapy. 2007 ; Vol. 5, No. 5. pp. 833-843.
@article{b3703cd10e2a4d32808ceaf294ad3a3c,
title = "Current concepts in antibiotic-resistant Gram-negative bacteria",
abstract = "Gram-negative bacteria are the dominant killers among bacterial pathogens in the intensive care unit. Antibiotic resistance has become a threat in hospital settings and efforts are being made to understand the underlying mechanisms. This review describes current data on the most important mechanisms of resistance in prevalent Gram-negative pathogens as well as newer therapeutic options.",
keywords = "Bacterial resistance, Carbapenems, Gram-negatives, Mechanisms of resistance, Tigecycline",
author = "{Torres Isasiga}, {Julian A.} and Villegas, {Maria Virginia} and Quinn, {John P.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1586/14787210.5.5.833",
language = "English (US)",
volume = "5",
pages = "833--843",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Current concepts in antibiotic-resistant Gram-negative bacteria

AU - Torres Isasiga, Julian A.

AU - Villegas, Maria Virginia

AU - Quinn, John P.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Gram-negative bacteria are the dominant killers among bacterial pathogens in the intensive care unit. Antibiotic resistance has become a threat in hospital settings and efforts are being made to understand the underlying mechanisms. This review describes current data on the most important mechanisms of resistance in prevalent Gram-negative pathogens as well as newer therapeutic options.

AB - Gram-negative bacteria are the dominant killers among bacterial pathogens in the intensive care unit. Antibiotic resistance has become a threat in hospital settings and efforts are being made to understand the underlying mechanisms. This review describes current data on the most important mechanisms of resistance in prevalent Gram-negative pathogens as well as newer therapeutic options.

KW - Bacterial resistance

KW - Carbapenems

KW - Gram-negatives

KW - Mechanisms of resistance

KW - Tigecycline

UR - http://www.scopus.com/inward/record.url?scp=35348982873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348982873&partnerID=8YFLogxK

U2 - 10.1586/14787210.5.5.833

DO - 10.1586/14787210.5.5.833

M3 - Review article

C2 - 17914917

AN - SCOPUS:35348982873

VL - 5

SP - 833

EP - 843

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

IS - 5

ER -